Dear All - I have a meeting this Friday 23rd. with the Director of Velindre Cancer Centre, Cardiff, and the Professor/Medical Director, plus a consultant radiologist - to discuss the findings from investigation into my case to date, and the responses from each clinical opinion in detail.
Oct. 2009: 'There are spotty, sclerotic areas throughout the thoracic & lumbar spine & also in the pelvis...findings would be consistent with bony metastatic disease'.
Jan. 2013: 'She has multiple small, sclerotic lesions in the spine & pelvis which were identified on CT in Oct.'09, and have not changed significantly in that time. The bone scan is normal. Recent MRI of spine is largely normal. The area of abnormality in femur is fairly indeterminate. We have come to the conclusion that the evidence for bony metastatic disease in this patient is tenuous. The small unchanged sclerotic lesions could well be related to a benign bone dysplasia.
I've outline my concerns to them, the main issue being that I wasn't informed or given opportunityto discuss uncertainty about mets/possible benign condition in Apr. 2011, when they first questioned it. From Nov. '12 I had m/x , 2nd lot of chemo (due to now HER2+, so herceptin needed), rads, change of AI - after 3 yrs. d/g with secondaries.
In recent letter from them they have put some responses from clinicians. It says that the consultant radiologist (who will go through imaging at the meeting) 'has highlighted that your case was not re-discussed at MDT until Oct.2012. Therefore the findings of the bone scan in March '11 & the CT in July '11 were not reviewed by the MDT, despite the concern raised in the reports regarding the diagnosis of bone metastases. She therefore does believe that there was a failure to discuss your case earlier at the MDT and this led to a delay in informing you of the doubt regarding the initial diagnosis'.
Any comments welcome!